CIA
MRKR icon

Concurrent Investment Advisors’s Marker Therapeutics MRKR Stock Holding History

Concurrent Investment Advisors’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$99.9K Buy
+67,963
New +$99.1K ﹤0.01% 2023

Other funds holding MRKR

IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
HNB
Hilltop National Bank Casper, Wyoming $468M AUM 36.09% 1-Year Est. Return

Concurrent Investment Advisors's MRKR Position: Q2 2026 in Review

Concurrent Investment Advisors opened a new position in Marker Therapeutics (MRKR) in Q2 2026: 67,963 shares worth $99.9K. The stake represents ﹤0.01% of the portfolio and ranks #2023 among its holdings.

5 funds tracked by Wall St. Rank hold MRKR as of Q2 2026.

  • Concurrent Investment Advisors held 67,963 shares of Marker Therapeutics worth $99.9K as of Q2 2026.
  • Marker Therapeutics was a new Concurrent Investment Advisors position in Q2 2026.
  • Marker Therapeutics made up ﹤0.01% of Concurrent Investment Advisors's portfolio in Q2 2026, its #2023 holding.
  • 5 funds tracked by Wall St. Rank held Marker Therapeutics as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.